Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

3(50.0%)

6Total

N/A(3)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06059898Not ApplicableCompleted

Magnesium NOVAMag® Membrane vs. Collagen Jason® Membrane in Patients Requiring Guided Bone Regeneration

Role: lead

NCT03089619Phase 4Terminated

Alveolar Management Following Teeth Extraction

Role: collaborator

NCT05171582Not ApplicableUnknown

Peri-implantitis Surgical Regenerative Therapy Using Bovine Bone Substitute With Hyaluronic Acid

Role: lead

NCT04854239Phase 4Completed

Accuracy of Half-guided Implant Placement

Role: collaborator

NCT04811768Phase 4Completed

Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation

Role: collaborator

NCT03163654Not ApplicableCompleted

Novel Porcine Dermal Matrix in the Treatment of Multiple Adjacent Gingival Recessions

Role: lead

All 6 trials loaded